Skip to main content
Search
Search
Australia
|
en
Choose Location
Americas
Asia Pacific
Europe
International
Middle East & Africa
Argentina |
es
Brazil |
pt
Canada |
en
Canada |
fr
Central America |
es
Colombia |
es
Mexico |
es
United States |
en
Venezuela |
es
Australia |
en
Bangladesh |
en
Hong Kong S.A.R. |
zh
India |
en
Indonesia |
en
Japan |
ja
Korea |
ko
Mainland China |
zh
Malaysia |
en
Pakistan |
en
Philippines |
en
Singapore |
en
Taiwan |
zh
Austria |
de
Belgium |
fr
Belgium |
nl
Bulgaria |
bg
Czech Republic |
cs
Czech Republic |
en
Denmark |
da
Estonia |
et
Finland |
fi
France |
fr
Germany |
de
Greece |
el
Hungary |
hu
Ireland |
en
Italy |
it
Latvia |
lv
Lithuania |
lt
Netherlands |
nl
Norway |
no
Poland |
pl
Portugal |
pt
Romania |
ro
Russia |
ru
Serbia |
sr
Slovakia |
sk
Spain |
es
Sweden |
sv
Switzerland |
de
Switzerland |
fr
United Kingdom |
en
Global |
en
Novartis Foundation |
en
Sandoz |
en
Egypt |
en
Israel |
he
South Africa |
en
Turkey |
tr
Australia
Choose Location
asia-pacific
Americas
Asia Pacific
Europe
International
Middle East & Africa
Argentina |
es
Australia |
en
Austria |
de
Bangladesh |
en
Belgium |
fr
Belgium |
nl
Brazil |
pt
Bulgaria |
bg
Canada |
en
Canada |
fr
Central America |
es
Colombia |
es
Czech Republic |
cs
Czech Republic |
en
Denmark |
da
Egypt |
en
Estonia |
et
Finland |
fi
France |
fr
Germany |
de
Global |
en
Greece |
el
Hong Kong S.A.R. |
zh
Hungary |
hu
India |
en
Indonesia |
en
Ireland |
en
Israel |
he
Italy |
it
Japan |
ja
Korea |
ko
Latvia |
lv
Lithuania |
lt
Mainland China |
zh
Malaysia |
en
Mexico |
es
Netherlands |
nl
Norway |
no
Novartis Foundation |
en
Pakistan |
en
Philippines |
en
Poland |
pl
Portugal |
pt
Romania |
ro
Russia |
ru
Sandoz |
en
Serbia |
sr
Singapore |
en
Slovakia |
sk
South Africa |
en
Spain |
es
Sweden |
sv
Switzerland |
de
Switzerland |
fr
Taiwan |
zh
Turkey |
tr
United Kingdom |
en
United States |
en
Venezuela |
es
Menu
About
Novartis Australia
Therapeutic areas of Novartis
Company History
Strategy
Diversity and Inclusion
People and Culture
Product Portfolio
Products - Consumer Information
Products - Healthcare Professionals
Our Business
Contact
About
Patients and Caregivers
Novartis Commitment to Patients and Caregivers
Diseases
Products - Consumer Information
Patients and Caregivers
Healthcare Professionals
Healthcare professional country resource
Products - Healthcare Professionals
Novartis Pipeline
Adverse Event Reporting
Novartis Clinical Trials
Healthcare Professionals
ESG
Financial Transparency for Australia
Financial Transparency for New Zealand
Grants
Patient Groups
Ethical Behavior
Code of Ethics
SpeakUp
Ethics, Risk and Compliance
Access
Environmental Sustainability
Global Health
ESG
News
News Archive
Media Contacts
News
Careers
Career Search
Meet the teams
Personal Growth
Early Talent
How We Work
Diversity and Inclusion
Career Programs
Awards & Recognition
Employee Benefits
Graduate Program
Learning and Development
Well-being
Careers
Coronavirus
Coronavirus
Adverse Event Reporting
Home
Document
Novartis_HCP Payment and ToV_20200501-20201031.xlsx